Buckingham Strategic Wealth’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,111
Closed -$25K 525
2019
Q4
$25K Hold
1,111
﹤0.01% 462
2019
Q3
$16K Hold
1,111
﹤0.01% 428
2019
Q2
$15K Hold
1,111
﹤0.01% 438
2019
Q1
$19K Hold
1,111
﹤0.01% 418
2018
Q4
$15K Hold
1,111
﹤0.01% 346
2018
Q3
$24K Sell
1,111
-1,000
-47% -$30.4K ﹤0.01% 357
2018
Q2
$90K Buy
+2,111
New +$96.7K 0.01% 350
2018
Q1
Sell
-2,111
Closed -$154K 350
2017
Q4
$154K Hold
2,111
0.03% 306
2017
Q3
$193K Sell
2,111
-111
-5% -$8.51K 0.05% 276
2017
Q2
$147K Hold
2,222
0.03% 288
2017
Q1
$482K Hold
2,222
0.14% 141
2016
Q4
$206K Hold
2,222
0.07% 219
2016
Q3
$300K Hold
2,222
0.1% 156
2016
Q2
$225K Hold
2,222
0.08% 203
2016
Q1
$364K Hold
2,222
0.12% 128
2015
Q4
$728K Hold
2,222
0.24% 73
2015
Q3
$717K Sell
2,222
-111
-5% -$48.8K 0.25% 70
2015
Q2
$930K Sell
2,333
-111
-5% -$47.2K 0.31% 62
2015
Q1
$1.2M Sell
2,444
-500
-17% -$194K 0.45% 43
2014
Q4
$1.05M Hold
2,944
0.41% 48
2014
Q3
$568K Hold
2,944
0.23% 70
2014
Q2
$704K Buy
+2,944
New +$599K 0.31% 60

Other funds holding LUMO

Buckingham Strategic Wealth's LUMO Position: Q1 2020 in Review

Buckingham Strategic Wealth sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 1,111 shares — an estimated $25K sold.

Buckingham Strategic Wealth first reported a position in LUMO in Q2 2014 and held it in 22 quarters. The position peaked at $1.2M in Q1 2015. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

  • Buckingham Strategic Wealth reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Buckingham Strategic Wealth sold 1,111 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $25K.
  • Buckingham Strategic Wealth first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2014 and held it in 22 quarters.
  • Buckingham Strategic Wealth's Lumos Pharma, Inc. Common Stock position peaked at $1.2M in Q1 2015.
  • 46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Buckingham Strategic Wealth's 13F filing for Q1 2020, filed 7 May 2020.